3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Glioma
3
Wilms Tumor
2
Prostatic Neoplasms
2
Glioblastoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Brain Neoplasms
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma of Lung
2
Solitary Fibrous Tumor, Pleural
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neuroblastoma
1
Neoplasms
1
Metastatic Malignant Female Reproductive System Neoplasm
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Germinoma
1
Ganglioneuroblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Ependymoma
1
Down Syndrome
1
Diabetes Insipidus
1
Central Nervous System Nongerminomatous Germ Cell Tumor
1
Central Nervous System Neoplasms
1
Interventions
durvalumab
13
Bevacizumab
11
Nivolumab
10
tremelimumab
7
pembrolizumab
6
lenvatinib
6
fludarabine
6
Cyclophosphamide
6
atezolizumab
4
Radiosurgery
4
Cisplatin
4
toripalimab
3
relatlimab
3
Magnetic Resonance Imaging
3
Ipilimumab
3
Gemcitabine
3
X-Rays
2
Standard of Care
2
Sorafenib
2
Riluzole
2
Radiotherapy
2
Photons
2
Patient Navigation
2
Lidocaine
2
Hepatectomy
2
Dexamethasone
2
Biopsy
2
trastuzumab deruxtecan
1
tocilizumab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Radiotherapy, Conformal
×
1 year
×
Clear all
No trials found.